ABOUT THE PRODUCT
CTX114 is a lead program advancing toward clinical trials, designed to slow or prevent vision loss in AMD patients.
Information is owner-confirmed
Last updated 4 months ago
Price range
Other products/services from Character Biosciences
CTX203
Biotechnology
N/A
Character Biosciences
United States (US)